- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak to partner in PACS with Perot Systems
Kodak to partner in PACS with Perot SystemsFilm and PACS company Eastman Kodak has signed a letter of intent with Perot Systems to work together on installing institution-wide PACS networks. Dallas-based Perot Systems will provide networking and
Kodak to partner in PACS with Perot Systems
Film and PACS company Eastman Kodak has signed a letter of intent with Perot Systems to work together on installing institution-wide PACS networks. Dallas-based Perot Systems will provide networking and integration services in large-scale PACS situations. The deal allows Kodak to offer customers both PACS and systems integration services, according to the Rochester, NY-based firm.
In other Kodak news, the firm is partnering with archiving firm Storage Technology of Louisville, CO, to bring support for digital linear tape to Kodak's long-term archiving offerings. The DLT addition will complement Kodak's other DICOM-compliant, long-term storage products, which include CD libraries.
The DLT subsystem employs the StorageTek automated cartridge system to meet department, hospital, or enterprise-wide long-term archiving needs, according to Kodak. Like the other two archiving levels in the Kodak Digital Science medical image and information library, the long-term archiving offering features JPEG data compression, autorouting, prefetching, and support for information transfer via Ethernet, 100 BaseT, ATM, T1, and ISDN lines.
- Search again
- Homepage
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
